Oramed Pharmaceuticals
ORMP
#8999
Rank
โ‚น12.49 B
Marketcap
โ‚น313.65
Share price
0.30%
Change (1 day)
65.91%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น76.75. In 2024 the company made an earnings per share (EPS) of -โ‚น45.48 a decrease over its 2023 EPS that were of โ‚น13.27.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-262.71%
2024-โ‚น45.48-442.86%
2023โ‚น13.27-114.89%
2022-โ‚น89.0720.51%
2021-โ‚น73.9139.29%
2020-โ‚น53.06-31.71%
2019-โ‚น77.70-4.65%
2018-โ‚น81.498.86%
2017-โ‚น74.86-9.2%
2016-โ‚น82.4429.85%
2015-โ‚น63.498.06%
2014-โ‚น58.755.08%
2013-โ‚น55.913.51%
2012-โ‚น54.01137.5%
2011-โ‚น22.74-60%
2010-โ‚น56.85-0%
2009-โ‚น56.85-16.67%
2008-โ‚น68.23-25%
2007-โ‚น90.97700%
2006-โ‚น11.37303.56%
2005-โ‚น2.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น336.46 338.37%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น195.69 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น553.38-820.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น18.00-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.43-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel